SlideShare a Scribd company logo
ERADICATING TUBERCULOSIS
IS FEASIBLE
PRESENTED BY:
JERRY SELASE SIFA
OUTLINE
• TUBERCULOSIS
• Brief History
• Burden of TB
• Global Trend
• Determinants of Disease
TUBERCULOSIS
• Agent: Mycobacterium tuberculosis
• Reservoir: Human beings
• Mode of transmission: Airborne
• Often affects the lungs (P.TB)
• Signs: Fever, fatigue, long cough, chest
pains etc
BRIEF HISTORY OF TB
• Evolved and acquired about 15,000 years
• Once endemic in Europe
• First described by Hippocrates
• Rober Koch (1882) established the mode of transmission
Burden of TB
• Top 10 causes of death worldwide
• In 2016:
 10.4 million people fell ill with TB
1.7 million died from the disease
 About 1 million children became ill with TB, and 250 000 children
died of TB
40% of HIV deaths were due to TB
BURDEN OF TB
• India, Indonesia, China, Philippines, Pakistan, Nigeria, and South Africa
bears 64% of the burden
• About 53 million lives were saved through TB diagnosis and treatment
between 2000 and 2015
• Multidrug-resistant TB (MDR-TB) remains a threat to global health
• Ending the TB epidemic by 2030 is among the health targets of the newly
adopted Sustainable Development Goals
GLOBAL TREND
DETERMINANTS OF DISEASE ERADICABILITY
Known etiology and epidemiology
Vaccine & Other tools
Human reservoir only
Political will/commitment
KNOWN ETIOLOGY & EPIDEMIOLOGY
• Etiology
• Person, Place, Time
Inform interventions
(e.g Interrupt transmission)
Saves resources
TOOLS- VACCINE
Currently:
Bacillus Calmette-Guerin (BCG)
 For Children
 Up to 80% protection
18% -99% coverage @ 2016
Ghana=94% @2016
Way Forward:
≥98% protection
100% coverage
Adults vaccine
TOOLS- DIAGNOSTIC
Currently
Microscopy
• 1/3 cases are missed
Equipment for LTBI
Way Forward
Observer bias immune tool
• PCR
TOOLS-TREATMENT
Current and way forward
1st: Rifampicin, Isonianzid,
Pyrizinamide, Ethambutol
• DOTS is still long
• MDR-8 months to 2years is long
• Adverse effects
HUMAN RESEVOIR
• Presence of other reservoirs
create room for reemergence
POLITICAL & HEALTH WORKER COMMITMENT
$162 billion needed (2017-2035)
Currently:
$2 billion deficit every year
Apathy in accepting vaccine
Unreached Communities
Way Forward
Step Up: Education, Screening,
Case finding
THANK YOU

More Related Content

What's hot

Modern technologies that help in the control of
Modern technologies that help in the control ofModern technologies that help in the control of
Modern technologies that help in the control of
X-tian Mike
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
anshumalaxalxo
 
Tuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationTuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health Presentation
Sharanya Rajan
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Abhay Rajpoot
 
Control of communicable diseases
Control of communicable diseases Control of communicable diseases
Control of communicable diseases
Rozelle Mae Birador
 
Pulmonary tuberculosis and its management
Pulmonary tuberculosis and its managementPulmonary tuberculosis and its management
Pulmonary tuberculosis and its management
Shweta Sharma
 
Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...
Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...
Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...
ijtsrd
 
TB(Tuberculosis)
TB(Tuberculosis)TB(Tuberculosis)
TB(Tuberculosis)
Suryachaudhary5
 
Tuberculosis at glance
Tuberculosis at glanceTuberculosis at glance
Tuberculosis at glance
Rehab India Foundation
 
Ntp
NtpNtp
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Jehad Alqurashi
 
Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology by Mul...
Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology  by Mul...Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology  by Mul...
Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology by Mul...
mulusew andualem
 
TB Talal qassem
 TB Talal qassem TB Talal qassem
TB Talal qassem
talloo
 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1
Suhail Naqvi
 
Communicable disease control
Communicable disease controlCommunicable disease control
Communicable disease control
Abdiwali Abdullahi Abdiwali
 
Epidemiology and control of tuberculosis and rntcp programme
Epidemiology and control of tuberculosis and rntcp programmeEpidemiology and control of tuberculosis and rntcp programme
Epidemiology and control of tuberculosis and rntcp programme
Joslita Dsouza
 
Communicable disease
Communicable diseaseCommunicable disease
Communicable disease
saif musadaq
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
hodmedicine
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
Jezza Agagas
 
Seminar on Pulmonary Tuberculosis
Seminar on Pulmonary TuberculosisSeminar on Pulmonary Tuberculosis
Seminar on Pulmonary Tuberculosis
suryakantsatpute1
 

What's hot (20)

Modern technologies that help in the control of
Modern technologies that help in the control ofModern technologies that help in the control of
Modern technologies that help in the control of
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationTuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health Presentation
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Control of communicable diseases
Control of communicable diseases Control of communicable diseases
Control of communicable diseases
 
Pulmonary tuberculosis and its management
Pulmonary tuberculosis and its managementPulmonary tuberculosis and its management
Pulmonary tuberculosis and its management
 
Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...
Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...
Clinic Epidemiological Characteristics of Chronic Hepatitis C on the Backgrou...
 
TB(Tuberculosis)
TB(Tuberculosis)TB(Tuberculosis)
TB(Tuberculosis)
 
Tuberculosis at glance
Tuberculosis at glanceTuberculosis at glance
Tuberculosis at glance
 
Ntp
NtpNtp
Ntp
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology by Mul...
Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology  by Mul...Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology  by Mul...
Update on Tuberculosis Transmission, Parthenogenesis and Epidemiology by Mul...
 
TB Talal qassem
 TB Talal qassem TB Talal qassem
TB Talal qassem
 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1
 
Communicable disease control
Communicable disease controlCommunicable disease control
Communicable disease control
 
Epidemiology and control of tuberculosis and rntcp programme
Epidemiology and control of tuberculosis and rntcp programmeEpidemiology and control of tuberculosis and rntcp programme
Epidemiology and control of tuberculosis and rntcp programme
 
Communicable disease
Communicable diseaseCommunicable disease
Communicable disease
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
 
Seminar on Pulmonary Tuberculosis
Seminar on Pulmonary TuberculosisSeminar on Pulmonary Tuberculosis
Seminar on Pulmonary Tuberculosis
 

Similar to Eradicating Tuberculosis is Feasible

tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptx
anjalatchi
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
AB Rajar
 
epidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdf
epidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdfepidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdf
epidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdf
ShakibSheikh5
 
Epidemiology and public health aspects of TB in india
Epidemiology and public health aspects of TB in indiaEpidemiology and public health aspects of TB in india
Epidemiology and public health aspects of TB in india
Shyam Ashtekar
 
world Tuberculosis day ppt 25-3-2024.pptx
world Tuberculosis day ppt 25-3-2024.pptxworld Tuberculosis day ppt 25-3-2024.pptx
world Tuberculosis day ppt 25-3-2024.pptx
naveenithkrishnan
 
MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...
MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...
MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...
info4africa
 
Tb epi
Tb epiTb epi
Tb epi
Geetha Mani
 
PRIMARY LEVEL CARE OF TUBERCULOSIS
PRIMARY LEVEL CARE OF TUBERCULOSISPRIMARY LEVEL CARE OF TUBERCULOSIS
PRIMARY LEVEL CARE OF TUBERCULOSIS
Keagan Kirugo
 
End tb
End tbEnd tb
End tb
Arkadeb Kar
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosis
AnuChalise
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
anjalatchi
 
Epidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by whoEpidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by who
Rama shankar
 
tuberculosis1-211129063858.pdf
tuberculosis1-211129063858.pdftuberculosis1-211129063858.pdf
tuberculosis1-211129063858.pdf
Racheal66
 
Tuberculosis TB
Tuberculosis TBTuberculosis TB
Tuberculosis TB
MUTUKURI RAKESH
 
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxepidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
DebdattaMandal5
 
RNTCP
RNTCPRNTCP
newrntcp-160127070415.pdf
newrntcp-160127070415.pdfnewrntcp-160127070415.pdf
newrntcp-160127070415.pdf
Manasranjanbehera43
 
Presentation10
Presentation10Presentation10
Presentation10
CierraLynn16
 
TB and pregnancy
TB and pregnancyTB and pregnancy
TB and pregnancy
NARENDRA C MALHOTRA
 
Tuberculosis revised guidelines - 2016
Tuberculosis   revised guidelines - 2016Tuberculosis   revised guidelines - 2016
Tuberculosis revised guidelines - 2016
Dr.Hemant Kumar
 

Similar to Eradicating Tuberculosis is Feasible (20)

tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptx
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
 
epidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdf
epidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdfepidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdf
epidemiologyandpublichealthaspectsoftbinindia-151118140427-lva1-app6892.pdf
 
Epidemiology and public health aspects of TB in india
Epidemiology and public health aspects of TB in indiaEpidemiology and public health aspects of TB in india
Epidemiology and public health aspects of TB in india
 
world Tuberculosis day ppt 25-3-2024.pptx
world Tuberculosis day ppt 25-3-2024.pptxworld Tuberculosis day ppt 25-3-2024.pptx
world Tuberculosis day ppt 25-3-2024.pptx
 
MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...
MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...
MRC/info4africa KZN Community Forum | July 2014 | Dr Elizabeth Spooner | TB i...
 
Tb epi
Tb epiTb epi
Tb epi
 
PRIMARY LEVEL CARE OF TUBERCULOSIS
PRIMARY LEVEL CARE OF TUBERCULOSISPRIMARY LEVEL CARE OF TUBERCULOSIS
PRIMARY LEVEL CARE OF TUBERCULOSIS
 
End tb
End tbEnd tb
End tb
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosis
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
 
Epidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by whoEpidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by who
 
tuberculosis1-211129063858.pdf
tuberculosis1-211129063858.pdftuberculosis1-211129063858.pdf
tuberculosis1-211129063858.pdf
 
Tuberculosis TB
Tuberculosis TBTuberculosis TB
Tuberculosis TB
 
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxepidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
 
RNTCP
RNTCPRNTCP
RNTCP
 
newrntcp-160127070415.pdf
newrntcp-160127070415.pdfnewrntcp-160127070415.pdf
newrntcp-160127070415.pdf
 
Presentation10
Presentation10Presentation10
Presentation10
 
TB and pregnancy
TB and pregnancyTB and pregnancy
TB and pregnancy
 
Tuberculosis revised guidelines - 2016
Tuberculosis   revised guidelines - 2016Tuberculosis   revised guidelines - 2016
Tuberculosis revised guidelines - 2016
 

Recently uploaded

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 

Recently uploaded (20)

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 

Eradicating Tuberculosis is Feasible

  • 2. OUTLINE • TUBERCULOSIS • Brief History • Burden of TB • Global Trend • Determinants of Disease
  • 3. TUBERCULOSIS • Agent: Mycobacterium tuberculosis • Reservoir: Human beings • Mode of transmission: Airborne • Often affects the lungs (P.TB) • Signs: Fever, fatigue, long cough, chest pains etc
  • 4. BRIEF HISTORY OF TB • Evolved and acquired about 15,000 years • Once endemic in Europe • First described by Hippocrates • Rober Koch (1882) established the mode of transmission
  • 5. Burden of TB • Top 10 causes of death worldwide • In 2016:  10.4 million people fell ill with TB 1.7 million died from the disease  About 1 million children became ill with TB, and 250 000 children died of TB 40% of HIV deaths were due to TB
  • 6. BURDEN OF TB • India, Indonesia, China, Philippines, Pakistan, Nigeria, and South Africa bears 64% of the burden • About 53 million lives were saved through TB diagnosis and treatment between 2000 and 2015 • Multidrug-resistant TB (MDR-TB) remains a threat to global health • Ending the TB epidemic by 2030 is among the health targets of the newly adopted Sustainable Development Goals
  • 8. DETERMINANTS OF DISEASE ERADICABILITY Known etiology and epidemiology Vaccine & Other tools Human reservoir only Political will/commitment
  • 9. KNOWN ETIOLOGY & EPIDEMIOLOGY • Etiology • Person, Place, Time Inform interventions (e.g Interrupt transmission) Saves resources
  • 10. TOOLS- VACCINE Currently: Bacillus Calmette-Guerin (BCG)  For Children  Up to 80% protection 18% -99% coverage @ 2016 Ghana=94% @2016 Way Forward: ≥98% protection 100% coverage Adults vaccine
  • 11. TOOLS- DIAGNOSTIC Currently Microscopy • 1/3 cases are missed Equipment for LTBI Way Forward Observer bias immune tool • PCR
  • 12. TOOLS-TREATMENT Current and way forward 1st: Rifampicin, Isonianzid, Pyrizinamide, Ethambutol • DOTS is still long • MDR-8 months to 2years is long • Adverse effects
  • 13. HUMAN RESEVOIR • Presence of other reservoirs create room for reemergence
  • 14. POLITICAL & HEALTH WORKER COMMITMENT $162 billion needed (2017-2035) Currently: $2 billion deficit every year Apathy in accepting vaccine Unreached Communities Way Forward Step Up: Education, Screening, Case finding

Editor's Notes

  1. TB is a caused by Mycobacterium TB. Most affect that most often affect the lung.
  2. Currently TB programmes us Microscopy
  3. Recommendations improve adherence leading to no treatment default
  4. 8.3 billion needed every year